Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus + Letrozole in Advanced ER+ Breast Cancer
NCT01231659Phase 2Completed
- Sponsor
- Novartis
- Start
- Aug 2011
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in breast cancer, sponsored by Novartis. Started Aug 2011; status: completed.
02
Drugs
everolimus
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01231659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01231659.